Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lymphoma, Large B-Cell, Diffuse|Cardiotoxicity|Left Ventricular Dysfunction|Chemotherapy Effect
Interventions: DRUG: Nebivolol|DRUG: Placebo
Sponsor: Giulio Stefanini
Collaborators: Agenzia Italiana del Farmaco